Ignite Creation Date:
2024-05-06 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02984215
Status:
COMPLETED
Last Update Posted:
2016-12-06
First Post:
2016-10-31
Brief Title:
aCGH Impacts Survival in Plasma Cell PTLD
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Array-CGH in Plasma Cell Post-transplantation Lymphoproliferative Disorders
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Plasma-cell post-transplantation lymphoproliferative disorders PC-PTLD are rare monomorphic PTLD divided into plasma cell myeloma PCM and plasmacytoma-like lesion PLL PTLD To date there is no exhaustive published cytogenetic data on PC-PTLD The investigators report array-based comparative genomic hybridization aCGH of 10 cases of PCM and PLL-PTLD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None